Some studies have demonstrated that the presence of elevated levels of αFP in patients with LC is a risk factor for the development of HCC [4-6], thus suggesting that increased αFP-production in patients with LC might reflect, largely and abnormal or altered liver cell regeneration. This evidence concerns the gene AFP and hepatocellular carcinoma.